Please login to the form below
Healthcare Glossary
A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W |
Opportunities to see (OTS)
The number of chances a reader/viewer will get to see an advertisement. A generic term used mainly in Europe describing frequency of media exposure. In the field of television, it is synonymous with frequency.
See also:
Opportunities to hear (OTH)
Related terms
Tonal bias, Tone of the media, Exclusive, Media planning, Cost-effectiveness (in media/advertising), Media mix, Above the fold, Collateral PR, Advertising agency's commission, Ambient media, Channels, Below the line , In-house newspaper/magazine, Above the line, Column inches,
COVID-19 Updates and Daily News
Featured jobs
-
Head of Health Psychology, London
-
Highly competitive salary
- Senior Account Executive, Medical/ Brand Communications, London
-
Highly competitive salary
- Senior Analyst, Market Access, UK, Home based
-
Highly competitive salary
-
Senior Health Psychologist, London
-
Highly competitive salary
- Recognising HIV Vaccine Awareness Day
- Scientists discover new approach to treat brain tumours
- NICE recommends AstraZeneca’s Imfinzi for adults with non-small cell lung cancer
- UICC launches global ATOM Coalition to increase access to essential cancer medicines
- Almirall and Evotec team up in multi-target dermatology alliance
- AstraZeneca’s COVID-19 vaccine receives EMA approval for use as third-dose booster
- How ‘Greenwashing’ accusations could delay the very changes its supporters demand
- A Medscape Oncology exclusive preview
- What does the future hold for clinical trial recruitment?
- New Pfizer initiative, ‘An Accord for a Healthier World’, launched to improve global health equity
- Results released from new study of AstraZeneca’s COVID-19 antibody
- Takeda and Daiichi Sankyo collaborate to create wearable device
- Roche shares new positive Ocrevus data for MS patients
- Almirall and Evotec team up in multi-target dermatology alliance
- Evolve, evolve, evolve; a call to action to all leaders in the healthcare industry
- Boehringer Ingelheim’s pulmonary fibrosis treatment produces promising phase 2 data
- First Herceptin biosimilar cleared in Europe
- India denies Vertex patent on cystic fibrosis drug Orkambi
PMHub
Merrill Brink International
Merrill Brink International is a leading provider of life sciences, legal, financial, manufacturing and corporate language solutions for global companies....
